207 related articles for article (PubMed ID: 26992905)
1. Overexpression of HDAC9 promotes oral squamous cell carcinoma growth, regulates cell cycle progression, and inhibits apoptosis.
Rastogi B; Raut SK; Panda NK; Rattan V; Radotra BD; Khullar M
Mol Cell Biochem; 2016 Apr; 415(1-2):183-96. PubMed ID: 26992905
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR-377 Promotes Oral Squamous Cell Carcinoma Growth and Migration by Targeting HDAC9.
Rastogi B; Kumar A; Raut SK; Panda NK; Rattan V; Joshi N; Khullar M
Cancer Invest; 2017 Mar; 35(3):152-162. PubMed ID: 28267394
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase 8 as a novel therapeutic target in oral squamous cell carcinoma.
Ahn MY; Yoon JH
Oncol Rep; 2017 Jan; 37(1):540-546. PubMed ID: 28004115
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.
Lapierre M; Linares A; Dalvai M; Duraffourd C; Bonnet S; Boulahtouf A; Rodriguez C; Jalaguier S; Assou S; Orsetti B; Balaguer P; Maudelonde T; Blache P; Bystricky K; Boulle N; Cavaillès V
Oncotarget; 2016 Apr; 7(15):19693-708. PubMed ID: 26930713
[TBL] [Abstract][Full Text] [Related]
5. Identifying targets for the restoration and reactivation of BRM.
Kahali B; Gramling SJ; Marquez SB; Thompson K; Lu L; Reisman D
Oncogene; 2014 Jan; 33(5):653-64. PubMed ID: 23524580
[TBL] [Abstract][Full Text] [Related]
6. Novel Interaction of Class IIb Histone Deacetylase 6 (HDAC6) with Class IIa HDAC9 Controls Gonadotropin Releasing Hormone (GnRH) Neuronal Cell Survival and Movement.
Salian-Mehta S; Xu M; McKinsey TA; Tobet S; Wierman ME
J Biol Chem; 2015 May; 290(22):14045-56. PubMed ID: 25873389
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of HDAC9 inhibits cell proliferation and tumor formation by inducing cell cycle arrest in retinoblastoma.
Zhang Y; Wu D; Xia F; Xian H; Zhu X; Cui H; Huang Z
Biochem Biophys Res Commun; 2016 Apr; 473(2):600-6. PubMed ID: 27033599
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma.
Sakuma T; Uzawa K; Onda T; Shiiba M; Yokoe H; Shibahara T; Tanzawa H
Int J Oncol; 2006 Jul; 29(1):117-24. PubMed ID: 16773191
[TBL] [Abstract][Full Text] [Related]
9. Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents.
Cheng AN; Jiang SS; Fan CC; Lo YK; Kuo CY; Chen CH; Liu YL; Lee CC; Chen WS; Huang TS; Wang TY; Lee AY
Cancer Lett; 2013 Sep; 337(2):218-25. PubMed ID: 23684929
[TBL] [Abstract][Full Text] [Related]
10. HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation.
Yang R; Wu Y; Wang M; Sun Z; Zou J; Zhang Y; Cui H
Oncotarget; 2015 Apr; 6(10):7644-56. PubMed ID: 25760078
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
12. Different class IIa HDACs repressive complexes regulate specific epigenetic responses related to cell survival in leiomyosarcoma cells.
Di Giorgio E; Dalla E; Franforte E; Paluvai H; Minisini M; Trevisanut M; Picco R; Brancolini C
Nucleic Acids Res; 2020 Jan; 48(2):646-664. PubMed ID: 31754707
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase 9 (HDAC9) regulates the functions of the ATDC (TRIM29) protein.
Yuan Z; Peng L; Radhakrishnan R; Seto E
J Biol Chem; 2010 Dec; 285(50):39329-38. PubMed ID: 20947501
[TBL] [Abstract][Full Text] [Related]
14. The HDAC inhibitor, panobinostat, induces apoptosis by suppressing the expresssion of specificity protein 1 in oral squamous cell carcinoma.
Jeon YJ; Ko SM; Cho JH; Chae JI; Shim JH
Int J Mol Med; 2013 Oct; 32(4):860-6. PubMed ID: 23877235
[TBL] [Abstract][Full Text] [Related]
15. Role for histone deacetylase 1 in human tumor cell proliferation.
Senese S; Zaragoza K; Minardi S; Muradore I; Ronzoni S; Passafaro A; Bernard L; Draetta GF; Alcalay M; Seiser C; Chiocca S
Mol Cell Biol; 2007 Jul; 27(13):4784-95. PubMed ID: 17470557
[TBL] [Abstract][Full Text] [Related]
16. Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression.
Lin GJ; Huang YS; Lin CK; Huang SH; Shih HM; Sytwu HK; Chen YW
Clin Oral Investig; 2016 Apr; 20(3):533-40. PubMed ID: 26205068
[TBL] [Abstract][Full Text] [Related]
17. Expression of HDAC9 in lung cancer--potential role in lung carcinogenesis.
Okudela K; Mitsui H; Suzuki T; Woo T; Tateishi Y; Umeda S; Saito Y; Tajiri M; Masuda M; Ohashi K
Int J Clin Exp Pathol; 2014; 7(1):213-20. PubMed ID: 24427341
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer.
Yang C; Croteau S; Hardy P
Cell Oncol (Dordr); 2021 Oct; 44(5):997-1017. PubMed ID: 34318404
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase 9 plays a role in the antifibrogenic effect of astaxanthin in hepatic stellate cells.
Yang Y; Bae M; Park YK; Lee Y; Pham TX; Rudraiah S; Manautou J; Koo SI; Lee JY
J Nutr Biochem; 2017 Feb; 40():172-177. PubMed ID: 27915160
[TBL] [Abstract][Full Text] [Related]
20. Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma.
Chiang WF; Hwang TZ; Hour TC; Wang LH; Chiu CC; Chen HR; Wu YJ; Wang CC; Wang LF; Chien CY; Chen JH; Hsu CT; Chen JY
Oral Oncol; 2013 Jun; 49(6):534-41. PubMed ID: 23375593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
